All Posts By

Smartkarma Daily Briefs

Daily Brief Energy/Materials: Crude Oil, Gevo, Lyondellbasell Indu Cl A, Packaging Corporation of America, Sky Quarry, Valaris , Amaroq Minerals , Valero Energy and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • [ETP 2025/13] WTI Climbs on Trade Disruptions, Moderate Weather Forecasts Cap Henry Hub
  • Gevo, Inc: 4Q24 Results
  • LYB US: Circular Plastics Initiative As a Significant Factor to Influence Future Performance!
  • Packaging Corporation of America: An Insight Into Its Market Adaptability
  • SKYQ: Co-Founder on How to Profit from Recycling Waste Asphalt Shingles into Fuel
  • Valaris Limited: Can It Capitalize On Offshore Expansion Opportunities?
  • Amaroq Minerals — Amaroq ‘n’ roll
  • Valero Energy Corporation’s Biofuel Strategy Is Turning Waste Into Gold—Can It Outrun Regulatory Shocks?


[ETP 2025/13] WTI Climbs on Trade Disruptions, Moderate Weather Forecasts Cap Henry Hub

By Suhas Reddy

  • For the week ending 21/Mar, U.S. crude inventories fell by 3.3m barrels (vs. expectations of 1.5m build), gasoline and distillate stockpiles fell less than expected.
  • US natural gas inventories rose by 37 Bcf for the week ending 21/Mar, in line with analyst expectations. Inventories are 6.5% below the 5-year seasonal average.
  • Shell to boost shareholder distributions to 40-50% of CFFO and cut costs by USD 5-7 billion by 2028. Exxon plans 250 layoffs in the UK by 2026.

Gevo, Inc: 4Q24 Results

By Water Tower Research

  • During the 2024 annual results briefing yesterday, Gevo management remained highly focused on the company’s strategy to: (1) develop and commercialize technologies to convert ethanol and other alcohols into hydrocarbon fuels and chemicals, including SAF and RNG
  • (2) establishing the carbon value of products by tracking and verifying sustainability attributes with Gevo’s Verity software
  • (3) monetizing the carbon abatement benefits of the company’s fuels and chemicals,

LYB US: Circular Plastics Initiative As a Significant Factor to Influence Future Performance!

By Baptista Research

  • LyondellBasell Industries N.V. showcased resilience in its financial performance over the challenging 2024 fiscal year, navigating a difficult macroeconomic environment.
  • The company’s full-year earnings per share stood at $6.40, with an EBITDA of $4.3 billion.
  • Despite facing significant industry headwinds, including sluggish global growth, high energy costs, and regulatory impacts, LyondellBasell successfully generated $3.8 billion in cash from operations, demonstrating a strong 90% cash conversion ratio.

Packaging Corporation of America: An Insight Into Its Market Adaptability

By Baptista Research

  • Packaging Corporation of America (PCA) demonstrated strong performance in their fourth quarter and throughout 2024.
  • The earnings call highlighted both positive accomplishments and challenges faced by the company.
  • PCA reported a notable increase in net income for the fourth quarter of 2024, amounting to $221 million, or $2.45 per share, compared to $192 million, or $2.13 per share, in the previous year.

SKYQ: Co-Founder on How to Profit from Recycling Waste Asphalt Shingles into Fuel

By Water Tower Research

  • On the latest WTR Small-Cap Spotlight, we were joined by Marcus Laun, Co-Founder and VP Executive of Sky Quarry (SKYQ), and our host, Tim Gerdeman, Vice-Chair & Co-Founder, and Chief Marketing Officer at WTR. 
  • SKYQ is an integrated energy solutions company created to address the environmental issues caused by the landfill disposal of waste asphalt roofing shingles.
  • According to SKYQ, millions of tons of waste asphalt shingle are generated annually in the US, which, if recycled, would equate to the recovery of 20-22 million barrels of oil and 9-11 million tons of valuable materials, and for a market valued at up to $4.4 billion.

Valaris Limited: Can It Capitalize On Offshore Expansion Opportunities?

By Baptista Research

  • Valaris plc reported its fourth quarter 2024 results, presenting a mixed performance.
  • While the company demonstrated strong operational execution and safety achievements, there were some financial challenges and strategic decisions that could impact future performance.
  • On the positive side, Valaris continued its track record of high operational efficiency, achieving fleet-wide revenue efficiency of 96% for the quarter and 97% for the entire year.

Amaroq Minerals — Amaroq ‘n’ roll

By Edison Investment Research

Amaroq’s results to December 2024 were essentially just a pro-rata extrapolation of its earlier, nine-month results to September. More important was the fact that Nalunaq poured its first gold (39oz – although this was evidently not sold during the quarter) and that, post period end, it recorded a 51% increase in its mineral resource estimate (including a maiden contribution in the indicated category). The company will spend the remainder of FY25 ramping up to full capacity of 300tpd by Q425 and will update the market on progress on 14 May. Once achieved, it will look to further increase throughput from FY26 to 450tpd.


Valero Energy Corporation’s Biofuel Strategy Is Turning Waste Into Gold—Can It Outrun Regulatory Shocks?

By Baptista Research

  • Valero Energy Corporation’s fourth quarter of 2024 performance reflects a mix of operational achievements and financial challenges.
  • The company reported a significant decrease in net income attributable to stockholders, down to $281 million ($0.88 per share) from $1.2 billion ($3.55 per share) in the same period of the previous year.
  • Adjusted net income also fell to $207 million ($0.64 per share) from $1.2 billion ($3.57 per share), indicating a challenging financial landscape amidst a weaker margin environment.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Daihatsu Diesel Mfg, Ashok Leyland, International Consolidated Air, GXO Logistics, Inpost, MillerKnoll, Sunrun Inc, Trimas Corp, Core & Main and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Daihatsu Diesel (6023) – Is Not Directly Auto-Tariff-Related
  • Ashok Leyland Restructuring: Switch UK Winds Down & Switch India’s Strategic Pivot
  • International Airlines Group — Come fly with me
  • GXO Logistics: Expansion into New Vertical Markets & Critical Growth Levers!
  • What’s New(s) in Amsterdam – 28 March (InPost | Signify)
  • International Airlines Group — Come fly with me
  • MillerKnoll, Inc. – 3Q25 Adj. EPS $0.44 on Lower-Than- Expected Revenue & Better Margins
  • Sunrun Inc.: Growth in Storage & Solar Markets Driving Our Bullishness!
  • TriMas Corporation: Packaging Expansion, Innovation & Growth in Aerospace & Other Major Drivers!
  • Core & Main Defies Market Volatility—The Power Moves Behind Their 2025 Growth Surge


Daihatsu Diesel (6023) – Is Not Directly Auto-Tariff-Related

By Travis Lundy

  • Daihatsu Diesel Mfg (6023 JP) is down sharply today – much more than indices – as autos/tech fall on US auto tariffs. There may be some GPIF unwinds as well. 
  • A reminder: Despite the name, Daihatsu Diesel is not an auto name, is growing, has a big order book, and minimal direct exposure to the US. 
  • The Tender settles today. The 8% overhang from Tendered-But-Unsold Shares is an opportunity, not a burden, at 7.2x ex-cash PER.

Ashok Leyland Restructuring: Switch UK Winds Down & Switch India’s Strategic Pivot

By Nimish Maheshwari

  • Ashok Leyland (AL IN) plans to shut manufacturing at its UK EV subsidiary, Switch Mobility UK, and shift focus to India and UAE plants.
  • The UK exit curbs cash burn and earnings drag, while Switch India, driven by rising demand, nears breakeven with 1800+ e-Bus orders and 80%+ e-LCV share.
  • This marks a value-accretive pivot, realigning capital to India’s high-growth EV market and improving group-level profitability and return metrics.

International Airlines Group — Come fly with me

By Edison Investment Research

International Airlines Group (IAG) enjoys the tailwinds of structural demand growth in an industry that is becoming more structurally profitable, being well positioned in some of the largest and most attractive markets, and with a portfolio of leading brands catering to the value requirements of its customers. While IAG already has industry-leading profitability, management is transforming it by investing in network expansion, customer service and operational efficiency to drive sustainable revenue growth and increase free cash flow.


GXO Logistics: Expansion into New Vertical Markets & Critical Growth Levers!

By Baptista Research

  • GXO Logistics, Inc. recently announced its fourth-quarter and full-year 2024 earnings, highlighting a period marked by robust growth, strategic achievements, and ongoing challenges.
  • The company reported record revenue and adjusted EBITDA for the year, with a 30% year-over-year increase in adjusted EBITDA for the fourth quarter alone.
  • Full-year revenue reached $11.7 billion, reflecting a 20% growth from the previous year, with 3% coming from organic growth.

What’s New(s) in Amsterdam – 28 March (InPost | Signify)

By The IDEA!

  • A summary of InPost’s FY24 results against consensus estimates and last year’s full year is presented in the table below.
  • InPost expects revenue to grow n the high-teens to low twenties range, and will surpass market volume growth in all our geographies, just like it did last year.
  • Adjusted EBITDA is foreseen to increase in the low to mid-twenties. 

International Airlines Group — Come fly with me

By Edison Investment Research

International Airlines Group (IAG) enjoys the tailwinds of structural demand growth in an industry that is becoming more structurally profitable, being well positioned in some of the largest and most attractive markets, and with a portfolio of leading brands catering to the value requirements of its customers. While IAG already has industry-leading profitability, management is transforming it by investing in network expansion, customer service and operational efficiency to drive sustainable revenue growth and increase free cash flow.


MillerKnoll, Inc. – 3Q25 Adj. EPS $0.44 on Lower-Than- Expected Revenue & Better Margins

By Water Tower Research

  • MLKN posted 3QFY25 adjusted EPS of $0.44, $0.01 below our estimate and 3QFY24 on weaker-than-expected revenue offset by better margins.
  • Total revenue came in $43 million lower than expected, with growth in Global Retail of 3.9% partially offsetting a decline in International Contract of 1.5% and modest growth in North America Contract of 1.7% on an organic basis.
  • Given how leading indicators in North America Contract had been trending positive over the past several quarters, we expected stronger revenue growth in 3QFY25.

Sunrun Inc.: Growth in Storage & Solar Markets Driving Our Bullishness!

By Baptista Research

  • Sunrun’s earnings for the fourth quarter and full year of 2024 presents a complex blend of progress and challenges, demonstrating the company’s navigational agility within a dynamic industry landscape.
  • The company reported strong quarterly performance, implementing strategic measures to enhance its operational and financial standing while managing market uncertainties.
  • The positives highlight Sunrun’s ability to adapt and innovate amid a rising interest rate environment and evolving state regulations.

TriMas Corporation: Packaging Expansion, Innovation & Growth in Aerospace & Other Major Drivers!

By Baptista Research

  • TriMas Corporation’s fourth-quarter and full-year 2024 results illustrate a company managing complexity across its diverse business segments while setting strategic groundwork for potential future improvements.
  • The fourth quarter showed several positive trends in financial and operational metrics, with consolidated sales up by 8.8% year-over-year, largely driven by strong performances in its Packaging and Aerospace segments.
  • In the Packaging segment, which accounts for 55% of total sales, TriMas achieved nearly 10% organic growth, particularly propelled by the beauty and personal care categories.

Core & Main Defies Market Volatility—The Power Moves Behind Their 2025 Growth Surge

By Baptista Research

  • Core & Main reported strong financial performance for the fiscal year 2024, marked by significant sales growth and strategic changes in the executive leadership team.
  • Sales increased by 18% in the fourth quarter, supported by a 9% contribution from acquisitions, and organic growth in average daily sales.
  • The company maintained stable gross margins and saw a slight increase in SG&A expenses, despite inflationary pressures, primarily due to acquisitions and additional costs associated with an extra selling week.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Amentum Holdings, Samsung Electronics Pref Shares, Analog Devices, CoreWeave, PChome Online, SentinelOne , Kuaishou Technology, Horizon Robotics, MoneyHero , Synaptics Inc and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • 4 Spin-offs with Insider Buying
  • The Hot Chatter in the Local Market: Tax-Free Dividends – Is Samsung In?
  • Analog Devices Pushing For Increased Industrial Automation With An Interesting Power-Saving Tech – What Does This Mean For Investors?
  • CoreWeave Inc (CRWV): IPO Opens Below Issue, Closes Flat in Debut Session
  • Tech Supply Chain Tracker (29-Mar-2025): Smart cars use DeepSeek apps.
  • SentinelOne Skyrockets with Enterprise Client Surge & Soaring Deal Sizes!
  • [Kuaishou (1024 HK, BUY, TP HK$70) TP Change]: C4Q24 Review: Temporary Setback a Chance to Buy
  • Horizon Robotics (9660.HK): The Stock Probably Peaked at HK$10.00+ As IPO Lock-Up Expires in April
  • MoneyHero: Three Key Questions Critical to the Investment Thesis
  • Synaptics Unleashes WiFi 8 & UWB Tech—Could This Be the Next Big Leap In IoT?


4 Spin-offs with Insider Buying

By Richard Howe

  • One factor that I closely follow in the spin-off universe is insider buying.
  • Here’s what Peter Lynch wrote about insiders and spin-offs in One Up on Wall Street: [Spin-offs] are a fertile area for amateur investors…….A month or two after the spinoff is completed, you can check to see if there is heavy insider buying among the new officers and directors.
  • There are four names in my universe that have interesting insider activity.

The Hot Chatter in the Local Market: Tax-Free Dividends – Is Samsung In?

By Sanghyun Park

  • Chosun reports that some Samsung affiliates are exploring tax-free dividends at the operational level, with execs reportedly briefed on the idea.
  • Surprisingly, regulators and politicians haven’t objected to tax-free dividends, which ironically align with the value-up policy. The delay in Samsung’s value-up announcements may be due to this decision.
  • It’s unclear if Samsung Electronics and Life will drop tax-free dividends, but if regulators approve, they could introduce it suddenly in their value-up updates, especially with Lee Jae-yong’s cash crunch.

Analog Devices Pushing For Increased Industrial Automation With An Interesting Power-Saving Tech – What Does This Mean For Investors?

By Baptista Research

  • Analog Devices, Inc. (ADI) reported its financial results for the first quarter of fiscal year 2025, showing better than-anticipated performance despite prevailing macroeconomic and geopolitical challenges.
  • Revenue reached $2.42 billion, surpassing the midpoint of its outlook, although this marked a 4% year-over-year decline.
  • When adjusted for an extra week in the comparable period last year, sales represented a 4% year-over-year increase.

CoreWeave Inc (CRWV): IPO Opens Below Issue, Closes Flat in Debut Session

By IPO Boutique

  • CoreWeave priced a down-sized transaction of 37.5mm shares at $40.00 ($7 Below the Original $47-$55 range) and opened at $39.00 for a loss of 2.5% at first trade
  • According to our underwriter sources, the deal finished multiple-times oversubscribed with the top three accounts getting 50% of the deal and the top 15 accounts taking down 90% of the transaction.
  • This IPO in particular was a difficult deal to value for IPO investors based upon being a “first mover” in the AI space.

Tech Supply Chain Tracker (29-Mar-2025): Smart cars use DeepSeek apps.

By Tech Supply Chain Tracker

  • DeepSeek app revolutionizes smart vehicles with advanced technology for a seamless driving experience and enhanced safety features.
  • Primarius enhances EDA consolidation in China through the acquisition of Actt, accelerating innovation and growth in the semiconductor industry.
  • SMIC experiences record revenue growth in 2024, but sees a 23% decline in profit, highlighting the challenges faced by the company in a competitive market. Trend Micro warns of AI security risks and ‘grandma prompt’ threat at the AI Expo 2025. Uni-President Group strengthens e-commerce presence through strategic acquisitions and investments in Yahoo Taiwan and PChome Online.

SentinelOne Skyrockets with Enterprise Client Surge & Soaring Deal Sizes!

By Baptista Research

  • SentinelOne reported strong financial results for the fourth quarter and fiscal year 2025, with significant achievements and certain challenges that are crucial for investors to assess.
  • The company experienced noteworthy revenue growth, reaching $226 million in Q4, marking a 29% increase year-over-year.
  • The total revenue for fiscal year 2025 amounted to $821 million, demonstrating an annual growth rate of 32%.

[Kuaishou (1024 HK, BUY, TP HK$70) TP Change]: C4Q24 Review: Temporary Setback a Chance to Buy

By Ying Pan

  • Kuaishou reported C4Q24 revenue, IFRS operating profit, and IFRS net income slightly below our estimates and consensus. Margin outperformed.
  • Advertising and e-commerce revenue growth temporarily slowed from due to Kuaishou’s offering traffic subsidies to the internal merchants, reducing incentive to advertise, but will translate to revenues later;
  • We cut TP from HK$72 to HK$70 to reflect lowered margin outlook due to AI-related capex and R&D expenses

Horizon Robotics (9660.HK): The Stock Probably Peaked at HK$10.00+ As IPO Lock-Up Expires in April

By Andrei Zakharov

  • Horizon Robotics, a leading provider of integrated computing solutions for ADAS and AD for consumer vehicles, went public in October of 2024 in Hong Kong.
  • The Chinese technology company priced its IPO at HK$3.99 per share and raised ~HK$5.4B or $696M. The offering was multiple times oversubscribed.
  • The company’s market cap peaked at ~$18B in February and exceeded valuation of Mobileye Global. I expect a near-term selling pressure as IPO lock-up expires in April.

MoneyHero: Three Key Questions Critical to the Investment Thesis

By Alec Tseung

  • We believe addressing these three key areas remains essential for strengthening the investment thesis and enhancing investors’ confidence in the company’s long-term value proposition.
  • 1) The company’s differentiation strategy within the relatively crowded Hong Kong and Singapore insurance marketplaces; 2) its insurance offerings’ product market fit; 3) disclosure on cross-selling metrics going forward
  • We think articulating a comprehensive strategy and detailed implementation roadmap, targeting these key areas, can enhance investor confidence and potentially provide support for the company’s valuation.

Synaptics Unleashes WiFi 8 & UWB Tech—Could This Be the Next Big Leap In IoT?

By Baptista Research

  • Synaptics Inc.’s second quarter fiscal year 2025 performance provides a multifaceted picture of the company’s current standing and future opportunities.
  • In this period, Synaptics reported revenue of $267 million, a 4% sequential increase and a 13% year-over-year rise, indicating modest growth driven primarily by gains in its Core IoT and Enterprise & Automotive sectors.
  • A significant topic of discussion was the company’s acquisition agreement with Broadcom, a $198 million all-cash transaction intended to enhance Synaptics’ presence in the wireless connectivity space.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Niox Group, Hygeia Healthcare Group, Bukwang Pharmaceutical, Cyberdyne Inc, Recce Ltd, Imunon , Lantern Pharma , QuidelOrtho , Certara and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • NIOX Group Faces Potential Acquisition by Keensight Capital Amid Ongoing Private Sale
  • Hygeia Healthcare Group (6078 HK): Slower Revenue Growth and Margin Deterioration Are Worrisome
  • Bukwang Pharm Announces A Capital Raise of 100 Billion Won
  • Cyberdyne (7779 JP) – Renewed Efforts to Drive Profitability
  • Recce Pharmaceuticals — Gearing up for an eventful year for R327G
  • IMNN: Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer
  • LTRN: 2024 Financial Results
  • QuidelOrtho Corporation: What Is Their Latest Strategic Shift In Revenue Focus?
  • Certara Inc.: Is The Biosimulation & Software Growth Here To Stay?


NIOX Group Faces Potential Acquisition by Keensight Capital Amid Ongoing Private Sale

By Special Situation Investments

  • NIOX Group received a non-binding takeover proposal from Keensight Capital at 81p/share, with a 9% spread.
  • NIOX’s management is open to the offer, having previously run a limited private sale process with ongoing negotiations.
  • Valuation at 81p/share aligns with industry standards, given NIOX’s growth, profitability, and upcoming product launches.

Hygeia Healthcare Group (6078 HK): Slower Revenue Growth and Margin Deterioration Are Worrisome

By Tina Banerjee

  • Hygeia Healthcare Group (6078 HK) reported revenue growth of 9% YoY to RMB4,446 million, mainly driven by a 11% YoY growth in hospital business.
  • Hygeia’s gross profit margin contracted 170bps YoY to 29.9%. Net profit decreased 13% on higher finance cost despite of income tax expenses being lower.
  • Accelerated organic growth and strengthening of margins are crucial to boost valuation.

Bukwang Pharm Announces A Capital Raise of 100 Billion Won

By Douglas Kim

  • On 28 March, Bukwang Pharmaceutical (003000 KS) announced a capital raise of 100 billion won. Its share price fell by 13.3% today. 
  • The company plans to issue 30.2 million new shares (44% of outstanding shares). Expected rights offering price is 3,310 won (15.1% lower than current price). 
  • We are negative on Bukwang Pharm mainly due to excessive shareholding dilution from this rights offering as well as lack of valuation merits. 

Cyberdyne (7779 JP) – Renewed Efforts to Drive Profitability

By Astris Advisory Japan

  • Cost-saving initiatives and divestment – Q1-3 FY3/25 results indicated continued traction for Treatment service in the Americas with 8.6% sales growth, but Product rental sales grew 0.6% YoY (-2.4% YoY under constant currency).
  • Operating losses are narrowing YoY, with the positive impact from cost reduction initiatives at Head Office costs as well as R&D.
  • We view the announcement to divest the 63.6%-owned subsidiary LeyLine GmbH as a positive surprise, as this will assist in narrowing operating losses further YoY into FY3/26. 

Recce Pharmaceuticals — Gearing up for an eventful year for R327G

By Edison Investment Research

Recce is preparing to start a registrational Indonesian Phase III study of the topical gel formulation (R327G) of its lead anti-infective therapeutic drug candidate, RECCE 327 (R327), for the treatment of diabetic foot infections (DFIs). We expect the trial to start in the coming weeks and note that DFIs are the leading cause of limb morbidity in diabetic patients and an area of unmet need as currently available topical drugs have limited effectiveness. We anticipate that positive results could lead to Recce’s earliest R327 commercialisation opportunity, through a launch in South-East Asia in the DFI indication in H2 CY26. After adjusting for forex and other minor adjustments, we now obtain an rNPV valuation of A$610.1m (or A$2.68 per share), versus A$593.6m (or A$2.60 per share) previously.


IMNN: Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer

By Zacks Small Cap Research

  • On March 25, 2025, Imunon, Inc. (IMNN) held a conference call to discuss the finalized protocol for a Phase 3 clinical trial of IMNN-001 in patients with newly diagnosed ovarian cancer.
  • The study will mirror the Phase 2 OVATION 2 trial that reported benefits in both progression-free and overall survival.
  • It will initially focus on those patients who are positive for homologous recombination deficiency (HDR) positive, including BRCA1 and BRCA2 mutations.

LTRN: 2024 Financial Results

By Zacks Small Cap Research

  • Lantern Pharma uses AI & data to identify drug responders, uncover mechanism of action & rescue failed drugs.
  • It is developing LP-300 for non- & never smoker NSCLC in the Harmonic trial.
  • Secondary candidates include LP-100 for mCRPC and LP-184 and LP-284 which are in clinical development for multiple biomarker-defined tumors and hematological cancers, respectively.

QuidelOrtho Corporation: What Is Their Latest Strategic Shift In Revenue Focus?

By Baptista Research

  • QuidelOrtho delivered results in line with their expectations for the full year 2024, closing the year with a total reported revenue of $2.8 billion.
  • The company noted a 4% decrease in fourth quarter revenue compared to the prior year, attributed largely to anticipated declines in COVID and flu testing revenues.
  • Notably, revenues from regions such as the Labs business, which grew by 4%, and the Immunohematology segment, which also rose by 4%, demonstrated stable performance and continued business growth irrespective of the broader respiratory revenue challenges.

Certara Inc.: Is The Biosimulation & Software Growth Here To Stay?

By Baptista Research

  • Certara reported robust financial performance for the fourth quarter and full year of 2024, reflecting a 9% growth in revenue to $385.1 million compared to the previous year.
  • The company experienced a stronger growth trajectory in the fourth quarter, with revenues reaching $100.4 million, marking a 14% year-over-year increase.
  • This growth was primarily fueled by a substantial 26% increase in software revenue, attributed to the robust demand for their biosimulation software and contributions from the recent acquisition of Chemaxon, which added $6.6 million to the reported revenue.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: NIFTY Index, Orion Holdings, Miniso, Lululemon Athletica, Innova Captab, Freshpet Inc, Hozon New Energy Automobile Co Ltd, Leon’S Furniture, Leggett & Platt, Pia Corp and more

By | Consumer, Daily Briefs

In today’s briefing:

  • NIFTY Outlook: Possible Breakout as Options Expiry Moves to Monday
  • Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (Starting 31 March 2025)
  • [Miniso Group (MNSO US, SELL, TP US$16) TP Change]: C4Q24 Review: Downside Not yet Fully Priced In
  • Lululemon 4Q’24 Update
  • Innova Captab’s Jammu Expansion Update
  • Freshpet’s Recent Market Growth & Household Penetration Expansion
  • Chinese EV Maker Neta on Brink of Collapse as $600 million Funding Round Falls Through
  • [Update] FY2024 Annual Report – Leon’s Furniture ($LNF , $LNF.TO)
  • Leggett & Platt: Focus On Expanding High-End Bedding Market To Enable Margin Expansion!
  • Pia Corp (4337 JP): Coverage Initiation


NIFTY Outlook: Possible Breakout as Options Expiry Moves to Monday

By Nico Rosti

  • The NIFTY Index had rallied quite hard the week before last week, then stalled last week, however its looks like maybe is changing in its trend structure, maybe a breakout
  • However the breakout may have to wait a bit more, as the NIFTY is overbought WEEKLY according to our model: before the uptrend resumes, there will be a pullback.
  • Last: as written by AceGama Advisors the WEEKLY options expiry will be moved from Thursday to Monday, starting in April 2025, impacting the market. Read their insight for detailed analysis.

Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (Starting 31 March 2025)

By Douglas Kim

  • In this insight, we provide the top 10 stocks picks and key catalysts in the Korean stock market for the two weeks starting 31 March.
  • The top 10 picks in this bi-weekly include Orion Holdings, Hyundai Wia, KEPCO KPS, Samsung Electronics, KT, Emart, CJ Logistics, APR, Doosan Enerbility, and HD Hyundai Marine Solution.
  • The biggest near-term negative catalyst on the Korean stock market remains tariffs. The final legal outcome on President Yoon Seok-Yeol is expected to be made by the end of April.

[Miniso Group (MNSO US, SELL, TP US$16) TP Change]: C4Q24 Review: Downside Not yet Fully Priced In

By Eric Wen

  • MNSO reported C4Q24 rev.1.6%/2.0%, and non-GAAP EBIT 3.4%/2.0% below our est./cons.. What concerns us more is the quality of the growth;
  • In our view, MNSO’s slow same-store-sales-growth (SSSG), overseas investment, and Yonghui’s integration haven’t fully reflected in the price;
  • We cut the TP to US$16 and maintain the SELL rating to reflect slower profit growth. The stock trades at 14x 25E P/E vs. a 12% 3 Yr. NI CAGR

Lululemon 4Q’24 Update

By MBI Deep Dives

  • Since its IPO back in 2007, Lululemon always posted double-digit revenue growth every single year.
  • While there was plenty of skepticism throughout 2024, they managed to eke out double digit growth last year.
  • But 2025 topline guidance of 5-7% implies the era of persistent double digit growth regardless of the economy is likely behind us!

Innova Captab’s Jammu Expansion Update

By Sudarshan Bhandari

  • Innova Captab (1605221D IN) has commissioned a new 11-acre manufacturing facility in Jammu, with capacity for 10.7 bn tablets and 562 mn LVP/respules.
  • The plant adds new dosage forms and therapy areas (Penicillin, Penum) and enables strategic domestic-export capacity balancing, with potential ROIC >20%.
  • This is not just a capacity bump, it positions Innova for premium exports, higher utilization, and long-term revenue scale-up to INR 14–16Bn from Jammu alone.

Freshpet’s Recent Market Growth & Household Penetration Expansion

By Baptista Research

  • Freshpet delivered a strong performance in the fiscal year 2024, characterized by notable growth in net sales and even more significant improvements in profitability.
  • The company’s net sales reached $975 million, marking a 27% increase from the previous year, driven largely by volume gains.
  • This was predominantly a result of increased household penetration and buy rates, boosted by strategic media investments and retail expansion.

Chinese EV Maker Neta on Brink of Collapse as $600 million Funding Round Falls Through

By Caixin Global

  • Neta Auto, the Chinese electric vehicle (EV) startup, is teetering on the brink of collapse after a funding crisis brought production to a standstill and triggered mass layoffs, leaving its parent company scrambling for a financial lifeline amid rising debt.
  • Hozon New Energy Automobile Co. Ltd., which produces EVs under the Neta brand, revealed in February that its much-anticipated Series E funding round had unraveled.
  • Originally scheduled to close by Feb. 28 with a planned injection of 4 billion to 4.5 billion yuan ($550 million to $620 million), the deal never materialized.

[Update] FY2024 Annual Report – Leon’s Furniture ($LNF , $LNF.TO)

By Unfair Advantage

  • ‘Loneliness is the feeling of isolation even when other people are there’ That’s how I feel about being a shareholder of Leon’s Furniture (LNF). Lonely.
  • No one talks about it, barring a few (Canadian Value Investor, Greystone).
  • 69% of LNF is owned by the Leon’s family and the stock continues to be illiquid despite being a 1 billion + market cap company in Canada.

Leggett & Platt: Focus On Expanding High-End Bedding Market To Enable Margin Expansion!

By Baptista Research

  • Leggett & Platt’s fourth-quarter and full-year 2024 results reflect a challenging market environment with mixed outcomes from restructuring efforts and demand dynamics across its segments.
  • Throughout 2024, Leggett & Platt undertook significant restructuring, particularly in its Bedding Products segment, as well as in home furniture, flooring products, and hydraulic cylinders.
  • The company exceeded its target for restructuring EBIT benefits, achieving $22 million, which was above the expected $10 million to $15 million, indicating successful execution of the restructuring plans.

Pia Corp (4337 JP): Coverage Initiation

By Shared Research

  • In FY03/24, revenue was JPY39.6bn (+20.8% YoY), operating profit JPY1.2bn (+47.4% YoY), recurring profit JPY922mn (+53.7% YoY), and net income attributable to owners of the parent JPY1.1bn (-21.0% YoY).
  • The Japanese leisure and audience entertainment market recovered, including in the live entertainment market.
  • In addition, major IT service providers such as LINE Ticket exited the market during the COVID-19 pandemic, reducing competitive pressure and providing a tailwind for the company.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Bombay Stock Exchange, Kolte Patil Developers, SmartStop Self Storage REIT and more

By | Daily Briefs, Financials

In today’s briefing:

  • How SEBI’s Expiry Date Proposal Could Halt BSE’s Market Share Erosion?
  • Kolte Patil: Q3FY25 Performance and Promoter Change Update
  • SmartStop Self Storage (SMA): CEO Confident in Bottoming Self-Storage Market Ahead of IPO


How SEBI’s Expiry Date Proposal Could Halt BSE’s Market Share Erosion?

By Sudarshan Bhandari

  • SEBI’s March 27 proposal suggests standardising expiry dates: Thursdays for Bombay Stock Exchange (BSE IN) and Tuesdays for National Stock Exchange (NSEIN IN) .
  • NSE’s previous strategic expiry days aimed at better liquidity, marginalising BSE’s Tuesday expiry, potentially impacting it’s trading volumes.
  • Post-Consultation was released, NSE faces a setback, deferring its planned monday expiry shift for Nifty contracts, indirectly protecting BSE from market share erosion.

Kolte Patil: Q3FY25 Performance and Promoter Change Update

By Ankit Agrawal, CFA

  • Kolte Patil’s Q3FY25 performance update’s key highlight was acquisition of a 22 acre joint development project with topline potential worth INR 4000cr representing saleable area of 5 Million Square Feet.
  • Q3FY25 pre-sales was not as robust as approval of new projects got delayed in Mumbai due to elections. However, Kolte Patil has guided to cover this up in early FY26.
  • Even with the delay, Kolte Patil is projecting to close FY25 pre-sales at INR 3000cr+ (vs INR 3500cr guided), which implies that Q4FY25 pre-sales could be INR 850cr+.

SmartStop Self Storage (SMA): CEO Confident in Bottoming Self-Storage Market Ahead of IPO

By IPO Boutique

  • The company is primarily a “growth by acquisition” story but does have a bullish outlook based upon strong occupancy and improving metrics.
  • The underwriters have reserved up to 10% of the shares in this offering through a directed share program.
  • This IPO “may” be more attractive for investors that “covet yield” versus traditional IPO players.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Recce Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Recce Pharmaceuticals — Gearing up for an eventful year for R327G


Recce Pharmaceuticals — Gearing up for an eventful year for R327G

By Edison Investment Research

Recce is preparing to start a registrational Indonesian Phase III study of the topical gel formulation (R327G) of its lead anti-infective therapeutic drug candidate, RECCE 327 (R327), for the treatment of diabetic foot infections (DFIs). We expect the trial to start in the coming weeks and note that DFIs are the leading cause of limb morbidity in diabetic patients and an area of unmet need as currently available topical drugs have limited effectiveness. We anticipate that positive results could lead to Recce’s earliest R327 commercialisation opportunity, through a launch in South-East Asia in the DFI indication in H2 CY26. After adjusting for forex and other minor adjustments, we now obtain an rNPV valuation of A$610.1m (or A$2.68 per share), versus A$593.6m (or A$2.60 per share) previously.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Hygeia Healthcare Group, Miniso, Horizon Robotics, Hozon New Energy Automobile Co Ltd, Kuaishou Technology, ENN Natural Gas and more

By | China, Daily Briefs

In today’s briefing:

  • Hygeia Healthcare Group (6078 HK): Slower Revenue Growth and Margin Deterioration Are Worrisome
  • [Miniso Group (MNSO US, SELL, TP US$16) TP Change]: C4Q24 Review: Downside Not yet Fully Priced In
  • Horizon Robotics (9660.HK): The Stock Probably Peaked at HK$10.00+ As IPO Lock-Up Expires in April
  • Chinese EV Maker Neta on Brink of Collapse as $600 million Funding Round Falls Through
  • [Kuaishou (1024 HK, BUY, TP HK$70) TP Change]: C4Q24 Review: Temporary Setback a Chance to Buy
  • Lucror Analytics – Morning Views Asia


Hygeia Healthcare Group (6078 HK): Slower Revenue Growth and Margin Deterioration Are Worrisome

By Tina Banerjee

  • Hygeia Healthcare Group (6078 HK) reported revenue growth of 9% YoY to RMB4,446 million, mainly driven by a 11% YoY growth in hospital business.
  • Hygeia’s gross profit margin contracted 170bps YoY to 29.9%. Net profit decreased 13% on higher finance cost despite of income tax expenses being lower.
  • Accelerated organic growth and strengthening of margins are crucial to boost valuation.

[Miniso Group (MNSO US, SELL, TP US$16) TP Change]: C4Q24 Review: Downside Not yet Fully Priced In

By Eric Wen

  • MNSO reported C4Q24 rev.1.6%/2.0%, and non-GAAP EBIT 3.4%/2.0% below our est./cons.. What concerns us more is the quality of the growth;
  • In our view, MNSO’s slow same-store-sales-growth (SSSG), overseas investment, and Yonghui’s integration haven’t fully reflected in the price;
  • We cut the TP to US$16 and maintain the SELL rating to reflect slower profit growth. The stock trades at 14x 25E P/E vs. a 12% 3 Yr. NI CAGR

Horizon Robotics (9660.HK): The Stock Probably Peaked at HK$10.00+ As IPO Lock-Up Expires in April

By Andrei Zakharov

  • Horizon Robotics, a leading provider of integrated computing solutions for ADAS and AD for consumer vehicles, went public in October of 2024 in Hong Kong.
  • The Chinese technology company priced its IPO at HK$3.99 per share and raised ~HK$5.4B or $696M. The offering was multiple times oversubscribed.
  • The company’s market cap peaked at ~$18B in February and exceeded valuation of Mobileye Global. I expect a near-term selling pressure as IPO lock-up expires in April.

Chinese EV Maker Neta on Brink of Collapse as $600 million Funding Round Falls Through

By Caixin Global

  • Neta Auto, the Chinese electric vehicle (EV) startup, is teetering on the brink of collapse after a funding crisis brought production to a standstill and triggered mass layoffs, leaving its parent company scrambling for a financial lifeline amid rising debt.
  • Hozon New Energy Automobile Co. Ltd., which produces EVs under the Neta brand, revealed in February that its much-anticipated Series E funding round had unraveled.
  • Originally scheduled to close by Feb. 28 with a planned injection of 4 billion to 4.5 billion yuan ($550 million to $620 million), the deal never materialized.

[Kuaishou (1024 HK, BUY, TP HK$70) TP Change]: C4Q24 Review: Temporary Setback a Chance to Buy

By Ying Pan

  • Kuaishou reported C4Q24 revenue, IFRS operating profit, and IFRS net income slightly below our estimates and consensus. Margin outperformed.
  • Advertising and e-commerce revenue growth temporarily slowed from due to Kuaishou’s offering traffic subsidies to the internal merchants, reducing incentive to advertise, but will translate to revenues later;
  • We cut TP from HK$72 to HK$70 to reflect lowered margin outlook due to AI-related capex and R&D expenses

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In the US, the third estimate of Q4/24 annualised US GDP inched up to 2.4% q-o-q (from 2.3% in the second estimate), mainly reflecting a downward revision to imports.
  • Separately, February pending home sales rose 2.0% m-o-m (1.0% e / -4.6% p), rebounding slightly from a record low but remaining well below historical levels.
  • The UST curve twisted steeper yesterday, with long-end yields rising to a one-month-high amid concerns over the impact of tariffs on US growth and inflation. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Samsung Electronics Pref Shares, Orion Holdings, Bukwang Pharmaceutical and more

By | Daily Briefs, South Korea

In today’s briefing:

  • The Hot Chatter in the Local Market: Tax-Free Dividends – Is Samsung In?
  • Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (Starting 31 March 2025)
  • Bukwang Pharm Announces A Capital Raise of 100 Billion Won


The Hot Chatter in the Local Market: Tax-Free Dividends – Is Samsung In?

By Sanghyun Park

  • Chosun reports that some Samsung affiliates are exploring tax-free dividends at the operational level, with execs reportedly briefed on the idea.
  • Surprisingly, regulators and politicians haven’t objected to tax-free dividends, which ironically align with the value-up policy. The delay in Samsung’s value-up announcements may be due to this decision.
  • It’s unclear if Samsung Electronics and Life will drop tax-free dividends, but if regulators approve, they could introduce it suddenly in their value-up updates, especially with Lee Jae-yong’s cash crunch.

Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (Starting 31 March 2025)

By Douglas Kim

  • In this insight, we provide the top 10 stocks picks and key catalysts in the Korean stock market for the two weeks starting 31 March.
  • The top 10 picks in this bi-weekly include Orion Holdings, Hyundai Wia, KEPCO KPS, Samsung Electronics, KT, Emart, CJ Logistics, APR, Doosan Enerbility, and HD Hyundai Marine Solution.
  • The biggest near-term negative catalyst on the Korean stock market remains tariffs. The final legal outcome on President Yoon Seok-Yeol is expected to be made by the end of April.

Bukwang Pharm Announces A Capital Raise of 100 Billion Won

By Douglas Kim

  • On 28 March, Bukwang Pharmaceutical (003000 KS) announced a capital raise of 100 billion won. Its share price fell by 13.3% today. 
  • The company plans to issue 30.2 million new shares (44% of outstanding shares). Expected rights offering price is 3,310 won (15.1% lower than current price). 
  • We are negative on Bukwang Pharm mainly due to excessive shareholding dilution from this rights offering as well as lack of valuation merits. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Amentum Holdings, Analog Devices, Lululemon Athletica, CoreWeave, Crude Oil, MoneyHero , Imunon , Freshpet Inc, Leggett & Platt, SentinelOne and more

By | Daily Briefs, United States

In today’s briefing:

  • 4 Spin-offs with Insider Buying
  • Analog Devices Pushing For Increased Industrial Automation With An Interesting Power-Saving Tech – What Does This Mean For Investors?
  • Lululemon 4Q’24 Update
  • CoreWeave Inc (CRWV): IPO Opens Below Issue, Closes Flat in Debut Session
  • [ETP 2025/13] WTI Climbs on Trade Disruptions, Moderate Weather Forecasts Cap Henry Hub
  • MoneyHero: Three Key Questions Critical to the Investment Thesis
  • IMNN: Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer
  • Freshpet’s Recent Market Growth & Household Penetration Expansion
  • Leggett & Platt: Focus On Expanding High-End Bedding Market To Enable Margin Expansion!
  • SentinelOne Skyrockets with Enterprise Client Surge & Soaring Deal Sizes!


4 Spin-offs with Insider Buying

By Richard Howe

  • One factor that I closely follow in the spin-off universe is insider buying.
  • Here’s what Peter Lynch wrote about insiders and spin-offs in One Up on Wall Street: [Spin-offs] are a fertile area for amateur investors…….A month or two after the spinoff is completed, you can check to see if there is heavy insider buying among the new officers and directors.
  • There are four names in my universe that have interesting insider activity.

Analog Devices Pushing For Increased Industrial Automation With An Interesting Power-Saving Tech – What Does This Mean For Investors?

By Baptista Research

  • Analog Devices, Inc. (ADI) reported its financial results for the first quarter of fiscal year 2025, showing better than-anticipated performance despite prevailing macroeconomic and geopolitical challenges.
  • Revenue reached $2.42 billion, surpassing the midpoint of its outlook, although this marked a 4% year-over-year decline.
  • When adjusted for an extra week in the comparable period last year, sales represented a 4% year-over-year increase.

Lululemon 4Q’24 Update

By MBI Deep Dives

  • Since its IPO back in 2007, Lululemon always posted double-digit revenue growth every single year.
  • While there was plenty of skepticism throughout 2024, they managed to eke out double digit growth last year.
  • But 2025 topline guidance of 5-7% implies the era of persistent double digit growth regardless of the economy is likely behind us!

CoreWeave Inc (CRWV): IPO Opens Below Issue, Closes Flat in Debut Session

By IPO Boutique

  • CoreWeave priced a down-sized transaction of 37.5mm shares at $40.00 ($7 Below the Original $47-$55 range) and opened at $39.00 for a loss of 2.5% at first trade
  • According to our underwriter sources, the deal finished multiple-times oversubscribed with the top three accounts getting 50% of the deal and the top 15 accounts taking down 90% of the transaction.
  • This IPO in particular was a difficult deal to value for IPO investors based upon being a “first mover” in the AI space.

[ETP 2025/13] WTI Climbs on Trade Disruptions, Moderate Weather Forecasts Cap Henry Hub

By Suhas Reddy

  • For the week ending 21/Mar, U.S. crude inventories fell by 3.3m barrels (vs. expectations of 1.5m build), gasoline and distillate stockpiles fell less than expected.
  • US natural gas inventories rose by 37 Bcf for the week ending 21/Mar, in line with analyst expectations. Inventories are 6.5% below the 5-year seasonal average.
  • Shell to boost shareholder distributions to 40-50% of CFFO and cut costs by USD 5-7 billion by 2028. Exxon plans 250 layoffs in the UK by 2026.

MoneyHero: Three Key Questions Critical to the Investment Thesis

By Alec Tseung

  • We believe addressing these three key areas remains essential for strengthening the investment thesis and enhancing investors’ confidence in the company’s long-term value proposition.
  • 1) The company’s differentiation strategy within the relatively crowded Hong Kong and Singapore insurance marketplaces; 2) its insurance offerings’ product market fit; 3) disclosure on cross-selling metrics going forward
  • We think articulating a comprehensive strategy and detailed implementation roadmap, targeting these key areas, can enhance investor confidence and potentially provide support for the company’s valuation.

IMNN: Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer

By Zacks Small Cap Research

  • On March 25, 2025, Imunon, Inc. (IMNN) held a conference call to discuss the finalized protocol for a Phase 3 clinical trial of IMNN-001 in patients with newly diagnosed ovarian cancer.
  • The study will mirror the Phase 2 OVATION 2 trial that reported benefits in both progression-free and overall survival.
  • It will initially focus on those patients who are positive for homologous recombination deficiency (HDR) positive, including BRCA1 and BRCA2 mutations.

Freshpet’s Recent Market Growth & Household Penetration Expansion

By Baptista Research

  • Freshpet delivered a strong performance in the fiscal year 2024, characterized by notable growth in net sales and even more significant improvements in profitability.
  • The company’s net sales reached $975 million, marking a 27% increase from the previous year, driven largely by volume gains.
  • This was predominantly a result of increased household penetration and buy rates, boosted by strategic media investments and retail expansion.

Leggett & Platt: Focus On Expanding High-End Bedding Market To Enable Margin Expansion!

By Baptista Research

  • Leggett & Platt’s fourth-quarter and full-year 2024 results reflect a challenging market environment with mixed outcomes from restructuring efforts and demand dynamics across its segments.
  • Throughout 2024, Leggett & Platt undertook significant restructuring, particularly in its Bedding Products segment, as well as in home furniture, flooring products, and hydraulic cylinders.
  • The company exceeded its target for restructuring EBIT benefits, achieving $22 million, which was above the expected $10 million to $15 million, indicating successful execution of the restructuring plans.

SentinelOne Skyrockets with Enterprise Client Surge & Soaring Deal Sizes!

By Baptista Research

  • SentinelOne reported strong financial results for the fourth quarter and fiscal year 2025, with significant achievements and certain challenges that are crucial for investors to assess.
  • The company experienced noteworthy revenue growth, reaching $226 million in Q4, marking a 29% increase year-over-year.
  • The total revenue for fiscal year 2025 amounted to $821 million, demonstrating an annual growth rate of 32%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars